Selected research
Industry Research
Pet Drug and Vaccine Industry Research Report 2026
Market perspective
The global Pet Drug and Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Pet Drug and Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pet Drug and Vaccine market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pet Drug and Vaccine market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pet Drug and Vaccine include Boehringer Ingelheim, Ceva, Dechra Veterinary Products, Elanco Animal Health, Meiji, Merck Animal Health, Ouro Fino Saude, Parnell and Vetoquinol, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Pet Drug and Vaccine market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pet Drug and Vaccine.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pet Drug and Vaccine Market by Company
Boehringer Ingelheim
Ceva
Dechra Veterinary Products
Elanco Animal Health
Meiji
Merck Animal Health
Ouro Fino Saude
Parnell
Vetoquinol
Virbac
Zoetis
Pet Drug and Vaccine Segment by Type
Drugs
Vaccine
Pet Drug and Vaccine Segment by Application
Dogs
Cats
Other
Pet Drug and Vaccine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Drug and Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pet Drug and Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Drug and Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pet Drug and Vaccine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Drugs
- Vaccine
Applications
- Dogs
- Cats
- Other
Companies covered
- Boehringer Ingelheim
- Ceva
- Dechra Veterinary Products
- Elanco Animal Health
- Meiji
- Merck Animal Health
- Ouro Fino Saude
- Parnell
- Vetoquinol
- Virbac
- Zoetis
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pet Drug and Vaccine by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Drugs
- 2.2.3 Vaccine
- 2.3 Pet Drug and Vaccine by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Dogs
- 2.3.3 Cats
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 Pet Drug and Vaccine Breakdown Data by Type
- 3.1 Global Pet Drug and Vaccine Historic Market Size by Type (2021-2026)
- 3.2 Global Pet Drug and Vaccine Forecasted Market Size by Type (2027-2032)
4 Pet Drug and Vaccine Breakdown Data by Application
- 4.1 Global Pet Drug and Vaccine Historic Market Size by Application (2021-2026)
- 4.2 Global Pet Drug and Vaccine Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pet Drug and Vaccine Market Perspective (2021-2032)
- 5.2 Global Pet Drug and Vaccine Growth Trends by Region
- 5.2.1 Global Pet Drug and Vaccine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pet Drug and Vaccine Historic Market Size by Region (2021-2026)
- 5.2.3 Pet Drug and Vaccine Forecasted Market Size by Region (2027-2032)
- 5.3 Pet Drug and Vaccine Market Dynamics
- 5.3.1 Pet Drug and Vaccine Industry Trends
- 5.3.2 Pet Drug and Vaccine Market Drivers
- 5.3.3 Pet Drug and Vaccine Market Challenges
- 5.3.4 Pet Drug and Vaccine Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pet Drug and Vaccine Players by Revenue
- 6.1.1 Global Top Pet Drug and Vaccine Players by Revenue (2021-2026)
- 6.1.2 Global Pet Drug and Vaccine Revenue Market Share by Players (2021-2026)
- 6.2 Global Pet Drug and Vaccine Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pet Drug and Vaccine Head Office and Area Served
- 6.4 Global Pet Drug and Vaccine Players, Product Type & Application
- 6.5 Global Pet Drug and Vaccine Manufacturers Established Date
- 6.6 Global Pet Drug and Vaccine Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pet Drug and Vaccine Market Size (2021-2032)
- 7.2 North America Pet Drug and Vaccine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pet Drug and Vaccine Market Size by Country (2021-2026)
- 7.4 North America Pet Drug and Vaccine Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pet Drug and Vaccine Market Size (2021-2032)
- 8.2 Europe Pet Drug and Vaccine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pet Drug and Vaccine Market Size by Country (2021-2026)
- 8.4 Europe Pet Drug and Vaccine Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pet Drug and Vaccine Market Size (2021-2032)
- 9.2 Asia-Pacific Pet Drug and Vaccine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pet Drug and Vaccine Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pet Drug and Vaccine Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pet Drug and Vaccine Market Size (2021-2032)
- 10.2 South America Pet Drug and Vaccine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pet Drug and Vaccine Market Size by Country (2021-2026)
- 10.4 South America Pet Drug and Vaccine Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pet Drug and Vaccine Market Size (2021-2032)
- 11.2 Middle East & Africa Pet Drug and Vaccine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pet Drug and Vaccine Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pet Drug and Vaccine Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Boehringer Ingelheim
- 12.1.1 Boehringer Ingelheim Company Information
- 12.1.2 Boehringer Ingelheim Business Overview
- 12.1.3 Boehringer Ingelheim Revenue in Pet Drug and Vaccine Business (2021-2026)
- 12.1.4 Boehringer Ingelheim Pet Drug and Vaccine Product Portfolio
- 12.1.5 Boehringer Ingelheim Recent Developments
- 12.2 Ceva
- 12.2.1 Ceva Company Information
- 12.2.2 Ceva Business Overview
- 12.2.3 Ceva Revenue in Pet Drug and Vaccine Business (2021-2026)
- 12.2.4 Ceva Pet Drug and Vaccine Product Portfolio
- 12.2.5 Ceva Recent Developments
- 12.3 Dechra Veterinary Products
- 12.3.1 Dechra Veterinary Products Company Information
- 12.3.2 Dechra Veterinary Products Business Overview
- 12.3.3 Dechra Veterinary Products Revenue in Pet Drug and Vaccine Business (2021-2026)
- 12.3.4 Dechra Veterinary Products Pet Drug and Vaccine Product Portfolio
- 12.3.5 Dechra Veterinary Products Recent Developments
- 12.4 Elanco Animal Health
- 12.4.1 Elanco Animal Health Company Information
- 12.4.2 Elanco Animal Health Business Overview
- 12.4.3 Elanco Animal Health Revenue in Pet Drug and Vaccine Business (2021-2026)
- 12.4.4 Elanco Animal Health Pet Drug and Vaccine Product Portfolio
- 12.4.5 Elanco Animal Health Recent Developments
- 12.5 Meiji
- 12.5.1 Meiji Company Information
- 12.5.2 Meiji Business Overview
- 12.5.3 Meiji Revenue in Pet Drug and Vaccine Business (2021-2026)
- 12.5.4 Meiji Pet Drug and Vaccine Product Portfolio
- 12.5.5 Meiji Recent Developments
- 12.6 Merck Animal Health
- 12.6.1 Merck Animal Health Company Information
- 12.6.2 Merck Animal Health Business Overview
- 12.6.3 Merck Animal Health Revenue in Pet Drug and Vaccine Business (2021-2026)
- 12.6.4 Merck Animal Health Pet Drug and Vaccine Product Portfolio
- 12.6.5 Merck Animal Health Recent Developments
- 12.7 Ouro Fino Saude
- 12.7.1 Ouro Fino Saude Company Information
- 12.7.2 Ouro Fino Saude Business Overview
- 12.7.3 Ouro Fino Saude Revenue in Pet Drug and Vaccine Business (2021-2026)
- 12.7.4 Ouro Fino Saude Pet Drug and Vaccine Product Portfolio
- 12.7.5 Ouro Fino Saude Recent Developments
- 12.8 Parnell
- 12.8.1 Parnell Company Information
- 12.8.2 Parnell Business Overview
- 12.8.3 Parnell Revenue in Pet Drug and Vaccine Business (2021-2026)
- 12.8.4 Parnell Pet Drug and Vaccine Product Portfolio
- 12.8.5 Parnell Recent Developments
- 12.9 Vetoquinol
- 12.9.1 Vetoquinol Company Information
- 12.9.2 Vetoquinol Business Overview
- 12.9.3 Vetoquinol Revenue in Pet Drug and Vaccine Business (2021-2026)
- 12.9.4 Vetoquinol Pet Drug and Vaccine Product Portfolio
- 12.9.5 Vetoquinol Recent Developments
- 12.10 Virbac
- 12.10.1 Virbac Company Information
- 12.10.2 Virbac Business Overview
- 12.10.3 Virbac Revenue in Pet Drug and Vaccine Business (2021-2026)
- 12.10.4 Virbac Pet Drug and Vaccine Product Portfolio
- 12.10.5 Virbac Recent Developments
- 12.11 Zoetis
- 12.11.1 Zoetis Company Information
- 12.11.2 Zoetis Business Overview
- 12.11.3 Zoetis Revenue in Pet Drug and Vaccine Business (2021-2026)
- 12.11.4 Zoetis Pet Drug and Vaccine Product Portfolio
- 12.11.5 Zoetis Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst